References
- Holden SE, Currie CJ, Owens DR. Evaluation of the clinical effectiveness in routine practice of fluocinolone acetonide intravitreal 190 µg implant in people with diabetic macular edema. Curr Med Res Opin 2017;33(Suppl):5--17
- Currie CJ, Holden SE, Berni E, Owens DR. Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes. Curr Med Res Opin 2017;33(Suppl):19--31
- Currie CJ, Holden SE, Owens DR. Change in retinal thickness following treatment with the intravitreal implant of fluocinolone acetonide 190 µg for diabetic macular edema. Curr Med Res Opin 2017;33(Suppl):33--43
- Holden SE, Currie CJ, Owens DR. Health economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema. Curr Med Res Opin 2017;33(Suppl):45--52
- Sharma S, Brown GC, Brown MM, et al. Converting visual acuity to utilities. Can J Ophthalmol 2000;35:267-72
- Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy. Available at: https://www.nice.org.uk/Guidance/TA301 [Last accessed 26 April 2017]